Stocks
GlaxoSmithKline (GSK) P/S US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 2.86 | 0.00 | 0.00 | 2.20 | 3.04 | 3.11 | ||
| Changes by years, y/y, % | -5% | -100% | +38% | +0.2% | |||||
GlaxoSmithKline. P/S
GlaxoSmithKline. P/S, changes, %
GlaxoSmithKline (GSK) P/S US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/S | ? | 2.71 | 3.02 | 1.51 | 3.39 | 3.17 | 3.11 | |
| Changes by years, y/y, % | +2% | +37% | -31% | +35% | +28% | |||
| Changes by quarters, q/q, % | +10% | +11% | -50% | +125% | -6% | |||
